Login / Signup

Impact of SARS-CoV-2 vaccines and recent chemotherapy on COVID-19 morbidity and mortality in patients with soft tissue sarcoma: an analysis from the OnCovid registry.

Bruno VincenziAlessio CortelliniAlessandro MazzoccaSarah OrlandoDavide RomandiniJuan AguilarIsabel Ruiz-CampsClaudia Valverde MoralesSimeon Eremiev-EremievCarlo TondiniJoan BrunetRossella BertulliSalvatore ProvenzanoMark BowerDaniele GeneraliRamon SalazarAnna SuredaAleix PratMichalarea VasilikiMieke Van HemelrijckAilsa Sita-LumsdenAlexia BertuzziSabrina RossiAmanda JacksonFederica GrossoAlvin J X LeeCian MurphyKatherine BelessiotisUma MukherjeeFanny PommeretAngela LoizidouGianluca GaidanoGino M DettorreSalvatore GrisantiMarco TucciClaudia A M FulgenziAlessandra GennariAndrea NapolitanoDavid J Pinato
Published in: Therapeutic advances in medical oncology (2024)
In this study, we demonstrate an improvement in COVID-19 outcomes in patients with STS over time. Recent exposure to chemotherapy does not impact COVID-19 morbidity and mortality and SARS-CoV-2 vaccination confers protection against adverse outcomes from COVID-19 in this patient population.
Keyphrases
  • sars cov
  • coronavirus disease
  • respiratory syndrome coronavirus
  • locally advanced
  • squamous cell carcinoma
  • type diabetes
  • emergency department
  • radiation therapy
  • skeletal muscle
  • weight loss
  • rectal cancer
  • adverse drug